NATIONAL WEEKLY INFLUENZA BULLETIN OF THE RUSSIAN FEDERATION
week 6 of 2023 (06.02.23 - 12.02.23)
Summary
Influenza and ARI incidence data. Influenza and other ARI activity increase of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (91.5 per 10 000 of population) was higer than national baseline (70.0) by 30.7%.
Etiology of ILI & ARI. Among 8284 patients investigation 909 (11.0%) respiratory samples were positive for influenza, including 188 cases of influenza A(H1N1)pdm09 in 34 cities, 3 cases of influenza A(H3N2) in 1 city, 69 cases of influenza A unsubtyped in 7 cities and 649 cases of influenza B in 40 cities.
67 influenza viruses were isolated on MDCK cell culture, including: 42 influenza A(H1N1)pdm09 viruses in Vladivostok (1), Yekaterinburg (3), Moscow (10), Orenburg (5), Saint-Petersburg (5), Stavropol (15), Tomsk (3); 25 influenza B viruses in Astrakhan (3), Vladivostok (10), Saint-Petersburg (10), Orenburg (2). Since the beginning of the season 822 influenza viruses were isolated on MDCK cell culture, including: 650 viruses A(H1N1)pdm09, 19 viruses A(H3N2) and 153 viruses B.
Antigenic characterization. Since the beginning of the season, 333 influenza A(H1N1)pdm09 viruses have been antigenically characterized by the NICs, including: Moscow (81) and Saint-Petersburg (252), 10 influenza A(H3N2) viruses in Saint-Petersburg and 58 influenza B, including: Moscow (7) and Saint-Petersburg (51). All viruses A(H1N1)pdm09 were antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09. All A(H3N2) strains were similar to the reference virus A/Darwin/9/2021. 56 influenza B viruses were antigenically similar to reference strain ÷/Austria/1359417/2021 and 2 influenza B viruses reacted with the reference virus antiserum to a 1:8 homologous titer.
Genetic analysis. Sequencing of 993 influenza viruses and isolates from primary clinical materials from patients was performed by the NIC (Saint-Petersburg). According to phylogenetic analysis, 904 influenza A(H1N1)pdm09 viruses were assigned to genetic subgroup 6 B.1A.5a.2 and similar to reference virus A/Victoria/2570/2019 (H1N1)pdm09; 27 A(H3N2) viruses was assigned to subgroup 3C.2 a1b.2a.2 and similar to reference virus Bangladesh/4005/2020 (H3N2); 62 influenza type B viruses were assigned to genetic subgroup V1A.3a.2 reference virus B/Austria/1359417/2021.Susceptibility to antivirals. All 58 influenza A(H1N1)pdm09 viruses analysed by the NIC (Saint-Petersburg) were susceptible to oseltamivir and zanamivir.
ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) was estimated in total as 16.5% (PCR).
In sentinel surveillance system clinical samples from 72 SARI patients were investigated by rRT-PCR for influenza, among them 14 (19.4%) cases of influenza, including 12 cases of influenza B and 2 cases of influenza A unsubtyped. Among 62 SARI samples 14 (22.6%) cases positive for ARVI detected including 7 cases of RSV, 4 cases of RhV, 2 cases of CoV and 1 case of BoV infection. 2 (2.8%) of 72 SARI patients were positive for coronavirus SARS-CoV-2.
Clinical samples from 40 ILI/ARI patients were investigated for influenza by rRT-PCR, among them 3 (7.5%) cases of influenza B. Among 35 ILI/ARI samples 5 (14.3%) cases positive for ARVI detected including 1 case of ADV, 3 cases of RhV and 1 case of MPV infection. 4 (10.0%) of 40 ILI/ARI patients were positive for coronavirus SARS-CoV-2.
COVID-19. Totally 22 121 725 cases and 395 689 deaths associated with COVID-19 were registered in Russia including 14 740 cases and 37 deaths in last 24 hours (on 12:00 of 16.02.2023). According to the data obtained by NIC in Saint-Petersburg totally 11 656 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 1480 (12.7%) cases.
Influenza and ARI morbidity data

Weeks
Morbidity 2022/23
Morbidity 2021/22
MEM baseline 2022/23
Epidemiological data showed increase of influenza and other ARI activity in Russia in comparison with previous week. The nationwide ILI and ARI morbidity level (91.5 per 10 000 of population) was higer than national baseline (70.0) by 30.7%.

Weeks
Season 2022/23
Season 2021/22
MEM baseline
Incidence rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.79 per 10 000 of population, it was higer than pre-epidemic MEM baseline (0.060).

Weeks
Season 2022/23
Season 2021/22
MEM baseline
Hospitalization rate of clinically diagnosed influenza decreased comparing to previous week and amounted to 0.18 per 10 000 of population, it was higer than pre-epidemic MEM baseline (0.040).
Influenza and ARVI laboratory testing results
Cumulative results of influenza laboratory diagnosis by rRT-PCR were submitted by 48 RBLs and two WHO NICs. According to these data as a result of 8284 patients investigation 909 (11.0%) respiratory samples were positive for influenza, including 188 cases of influenza A(H1N1)pdm09 in 34 cities, 3 cases of influenza A(H3N2) in 1 city, 69 cases of influenza A unsubtyped in 7 cities and 649 cases of influenza B in 40 cities.
67 influenza viruses were isolated on MDCK cell culture, including: 42 influenza A(H1N1)pdm09 viruses in Vladivostok (1), Yekaterinburg (3), Moscow (10), Orenburg (5), Saint-Petersburg (5), Stavropol (15), Tomsk (3); 25 influenza B viruses in Astrakhan (3), Vladivostok (10), Saint-Petersburg (10), Orenburg (2). Since the beginning of the season 822 influenza viruses were isolated on MDCK cell culture, including: 650 viruses A(H1N1)pdm09, 19 viruses A(H3N2) and 153 viruses B.
Antigenic characterization. Since the beginning of the season, 333 influenza A(H1N1)pdm09 viruses have been antigenically characterized by the NICs, including: Moscow (81) and Saint-Petersburg (252), 10 influenza A(H3N2) viruses in Saint-Petersburg and 58 influenza B, including: Moscow (7) and Saint-Petersburg (51). All viruses A(H1N1)pdm09 were antigenically similar to reference strain A/Victoria/2570/2019 (H1N1)pdm09. All A(H3N2) strains were similar to the reference virus A/Darwin/9/2021. 56 influenza B viruses were antigenically similar to reference strain ÷/Austria/1359417/2021 and 2 influenza B viruses reacted with the reference virus antiserum to a 1:8 homologous titer.Genetic analysis. Sequencing of 993 influenza viruses and isolates from primary clinical materials from patients was performed by the NIC (Saint-Petersburg). According to phylogenetic analysis, 904 influenza A(H1N1)pdm09 viruses were assigned to genetic subgroup 6 B.1A.5a.2 and similar to reference virus A/Victoria/2570/2019 (H1N1)pdm09; 27 A(H3N2) viruses was assigned to subgroup 3C.2 a1b.2a.2 and similar to reference virus Bangladesh/4005/2020 (H3N2); 62 influenza type B viruses were assigned to genetic subgroup V1A.3a.2 reference virus B/Austria/1359417/2021.Susceptibility to antivirals. All 58 influenza A(H1N1)pdm09 viruses analysed by the NIC (Saint-Petersburg) were susceptible to oseltamivir and zanamivir.

No data
No viruses detected
H1pdm09
H3
H3+H1pdm09
B
B+H1pdm09
B+H3
B+H3+H1pdm09
A (not subt.)
A (not subt.)+H1pdm09
A (not subt.)+H3
A (not subt.)+H3+H1pdm09
A (not subt.)+B
A (not subt.)+B+H1pdm09
A (not subt.)+B+H3
A (not subt.)+B+H3+H1pdm09

Weeks
H1pdm09
H3
B
A (not subt.)
% positive

Weeks
PIV
ADV
RSV
RhV
CoV
MPV
BoV
ARVI detections. The overall proportion of respiratory samples tested positive for other ARVI (PIV, ADV, RSV, RhV, CoV, MPV, BoV) estimated as 16.5% of investigated samples by PCR.

Weeks
H1pdm09
H3
B
% positive
Table 1. Results of influenza and other ARVI detection by RT-PCR in Russia, week 6 of 2023
Number of specimens / number of positive cases | % positive | |
Influenza | ||
Number of specimens tested for influenza | 8284 | - |
Influenza A (not subt.) | 69 | 0,8% |
Influenza A(H1)pdm09 | 188 | 2,3% |
Influenza A(H3) | 3 | 0,04% |
Influenza B | 649 | 7,8% |
All influenza | 909 | 11,0% |
Other ARVI | ||
Number of specimens tested for ARVI | 7468 | - |
PIV | 84 | 1,1% |
ADV | 82 | 1,1% |
RSV | 252 | 3,4% |
RhV | 349 | 4,7% |
CoV | 331 | 4,4% |
MPV | 106 | 1,4% |
BoV | 28 | 0,4% |
All ARVI | 1232 | 16,5% |
SARS-CoV-2 (COVID-19) | ||
Number of specimens tested for SARS-CoV-2 | 11656 | - |
SARS-CoV-2 | 1480 | 12,7% |

No data
less then 10%
10-20%
20-30%
30-40%
40-50%
50% and more
COVID-19. Totally 22 121 725 cases and 395 689 deaths associated with COVID-19 were registered in Russia including 14 740 cases and 37 deaths in last 24 hours (on 12:00 of 16.02.2023). According to the data obtained by NIC in Saint-Petersburg totally 11 656 clinical samples were PCR investigated in last week. Among them coronavirus SARS-CoV-2 detected in 1480 (12.7%) cases.
Table 2. Results of influenza viruses isolation in Russia, week 6 of 2023
Number of specimens / number of viruses | % isolated viruses | |
Number of specimens | 264 | - |
Influenza A(H1)pdm09 | 42 | 15,9% |
Influenza A(H3) | 0 | 0,0% |
Influenza B | 25 | 9,5% |
All influenza | 67 | 25,4% |
Sentinel influenza surveillance
ólinical samples from 72 SARI patients were investigated by rRT-PCR for influenza, among them 14 (19.4%) cases of influenza, including 12 cases of influenza B and 2 cases of influenza A unsubtyped. Among 62 SARI samples 14 (22.6%) cases positive for ARVI detected including 7 cases of RSV, 4 cases of RhV, 2 cases of CoV and 1 case of BoV infection. 2 (2.8%) of 72 SARI patients were positive for coronavirus SARS-CoV-2.
Clinical samples from 40 ILI/ARI patients were investigated for influenza by rRT-PCR, among them 3 (7.5%) cases of influenza B. Among 35 ILI/ARI samples 5 (14.3%) cases positive for ARVI detected including 1 case of ADV, 3 cases of RhV and 1 case of MPV infection. 4 (10.0%) of 40 ILI/ARI patients were positive for coronavirus SARS-CoV-2.

Weeks
H1pdm09
H3
B
A (not subt.)
% positive

Weeks
H1pdm09
H3
B
A (not subt.)
% positive

Weeks
PIV
ADV
RSV
RhV
CoV
MPV
BoV

Weeks
PIV
ADV
RSV
RhV
CoV
MPV
BoV